EXOZ

eXoZymes, Inc.

$4.04

-5.50%
SectorHealthcareIndustryBiotechnologyCountryUnited States

eXoZymes, Inc. operates as a development stage biotechnology company. It focuses on the development of enzyme modules and cell-free exozyme biosolutions for synthetic biology manufacturing. The company was formerly known as Invizyne Technologies, Inc. and changed its name to eXoZymes, Inc. in February 2025. eXoZymes, Inc. was incorporated in 2014 and is headquartered in Monrovia, California.

Source: Yahoo Finance
AI summary

Price & performance

1M-37.3%
3M-14.9%
YTD-63.6%
1Y-66.7%
52-week range—
Beta0.63
Full chart and returns against a benchmark

Q-Score

35/ 100

Quality against peers; 50 is the peer median.

Growth—
Risk52
Performance38
Valuation36
Profitability20
Leverage59
Sentiment—
Every score and metric

News sentiment

Open News

Latest results · FY 2025

Revenue—
Net income-$9.2M
Net margin—
Historical fundamentals

Red flags in filings

2active red flags
Going-concern doubtMar 30, 2026
Material weakness in controlsMar 30, 2026
Filings, findings and the timeline

Revenue exposure

Regions, segments, customers and suppliers

Valuation

EXOZIndustryP/E—89.69P/S—11.88EV/EBITDA—67.10P/B10.296.22PEG—4.02
Dividend yield0.00%
Every valuation metric